Business
Press Release Jul 30 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated July 30, 2021, titled " Zydus Cadila receives final approval from USFDA for Fulvestrant Injection".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated July 30, 2021, titled \" Zydus Cadila receives final approval from USFDA for Fulvestrant Injection\". View Attachment","length":336,"tagName":"div"}]